McNeil v. Jolly

CourtDistrict Court, E.D. Louisiana
DecidedApril 3, 2020
Docket2:14-cv-02247
StatusUnknown

This text of McNeil v. Jolly (McNeil v. Jolly) is published on Counsel Stack Legal Research, covering District Court, E.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McNeil v. Jolly, (E.D. La. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA

UNITED STATES OF AMERICA, CIVIL ACTION ex rel, TRECI MCNEIL, ET AL.

VERSUS No. 14-2247 c/w 15-877, 15-297, 15-1445, 16-15440 REF: ALL CASES

TARUN JOLLY, ET AL. SECTION I

ORDER & REASONS Before the Court are motions1 for attorneys’ fees, costs, and expenses filed by Treci McNeil (“McNeil”), Lindsey Lawson (“Lawson”) and Sheldon Green (“Green”), Bradley Church (“Church”),2 and Philip Bergeron (“Bergeron”). For the following reasons, McNeil’s motion is granted in part and denied in part, Lawson and Green’s motion is denied, Church’s motion is denied, and Bergeron’s motion is granted in part and denied in part. I. Between 2014 and 2015, McNeil, Lawson and Green, Church, Bergeron, and Kevin Outerbridge (“Outerbridge”) (collectively, “relators”) brought separate qui tam actions against, inter alia, defendants Tarun Jolly, M.D. (“Jolly”), Barry Griffith (“Griffith”), Patrick Ridgeway (“Ridgeway”), and UTC Laboratories, Inc., a/k/a RenRX

1 R. Doc. Nos. 55, 57, 58 & 59. 2 Church is referred to as “Doe” in his motion. R. Doc. No. 58. (“UTC”) for alleged violations of the Anti-Kickback Statute (“AKS”), 42 U.S.C. § 1320a-7b(b), and the Physician Self-Referral Law (“Stark Act”), 42 U.S.C. § 1395nn.3 The relators claimed that the defendants offered and paid remuneration to

physicians and other individuals to induce the ordering of medically unnecessary pharmacogenetic clinical laboratory tests, and submitted false claims to the Medicare program for reimbursement of such tests.4 Bergeron filed his qui tam action in the United States District Court for the Southern District of New York against, inter alia, Jolly, Griffith, Ridgeway, and UTC, and his case was transferred to this district in 2016.5 McNeil filed her qui tam action in this district against, inter alia, UTC and

Jolly.6 Lawson and Green filed their qui tam action in this district against UTC and another defendant who is not a party to this matter.7 Church filed his qui tam action in this district against UTC.8 Outerbridge filed his qui tam action in this district against UTC and Jolly.9

3 See R. Doc. No. 55-4, at 2–3. Outerbridge has not moved for attorneys’ fees, costs, and expenses. 4 See id., at 2. 5 Bergeron first filed his action against UTC and Syntactx, LLC on April 8, 2014. No. 2:16-cv-15440, R. Doc. No 1. He filed a first amended complaint, adding claims against Novitas Solutions, Inc., General Genetics Corporation, and Companion Dx Reference Lab, LLC. No. 2:16-cv-15440, R. Doc. No. 1-4. Jolly then filed a second amended complaint, adding claims against defendants Jolly, Griffith, and Ridgeway. No. 2:16-cv-15440, R. Doc. No. 1-7. Syntactx, LLC, Novitas Solutions, Inc., General Genetics Corporation, and Companion Dx Reference Lab, LLC are not a part of the global settlement agreement or parties to this matter. 6 R. Doc. No. 1. The other defendants named in McNeil’s complaint—Blue Ox Medical Innovations, LLC, Ryan Dienst, and Tanya Thomas—are not a part of the global settlement agreement or parties to this matter. 7 No. 2:15-cv-00297, R. Doc. No. 1. 8 No. 2:15-cv-00877, R. Doc. No. 1. 9 No. 2:15-cv-01445, R. Doc. No. 1. Pursuant to 28 U.S.C. § 3730(b)(2), a copy of each relator’s complaint and written disclosure of substantially all material evidence and information the relator possessed was served on the government. The government elected to intervene and

proceed in each of the relator’s actions, and it began investigations into the allegations raised in the relators’ complaints. After years of investigation, in September 2019, a global settlement agreement was reached between the government, the relators, and defendants Jolly, Griffith, Ridgeway, and UTC.10 Under the terms of the global settlement agreement, Jolly, Griffith, Ridgeway, and UTC were required to pay to the United States their

respective portions of the total settlement amount—$500,000 by Jolly, $250,000 by Griffith, $250,000 by Ridgeway, and $42,109,358.68 by UTC.11

10 R. Doc. No. 55-4. 11 R. Doc. No. 55-4, at 6–7; R. Doc. No. 70-2, at 2. UTC’s portion of the settlement amount included a “Suspended Amount” in Medicare payments to UTC that the Centers for Medicare & Medicaid Services retained based on credible allegations of fraud against UTC. See R. Doc. No. 55-4, at 5.

On October 4, 2019, the government filed, in each of the relator’s actions, a notice of intervention in part for purposes of settlement and declination in part. R. Doc. No. 45; R. Doc. No. 38, No. 2:15-cv-00877; R. Doc. No. 32, No. 2:15-cv-00297; R. Doc. No. 31, No. 2:15-cv-01445; R. Doc. No. 28, No. 2:16-cv-15440. In light of the global settlement agreement and for the purpose of effectuating and formalizing that resolution, the government advised the Court of its decision to intervene with respect to certain civil claims against defendants Jolly, Ridgeway, Griffith, and UTC. R. Doc. No. 45, at 2–3. The government also advised the Court that it declined intervention with respect to all other claims brought by the relators in their individual qui tam actions, as well as with respect to the remaining defendants in those actions. Id. at 3. Those defendants were named in the relators’ qui tam actions, but they are not parties to this matter or the global settlement agreement. Pursuant to the global settlement agreement, the relators agreed to release Jolly, Griffith, Ridgeway, and UTC from, inter alia, liability to all relators arising from the relators’ qui tam actions, “excluding claims under 31 U.S.C. § 3730(d) for

expenses or attorneys’ fees and costs.”12 The agreement also provided that the government and the relators agree that “they each retain all of their rights pursuant to the False Claims Act on the issue of the share percentage, if any, that Relators should receive of any proceeds of the settlement of their claim(s), and that no agreements concerning Relator share have been reached to date.”13 In January 2020, the government and the relators entered into a settlement

agreement (“Relators Settlement Agreement”) awarding shares of the proceeds from the global settlement agreement to Bergeron and McNeil.14 Specifically, Bergeron was awarded $8,211,324.94 of the settlement amount agreed upon by UTC, Ridgeway, Griffith, and the government, and McNeil was awarded $110,000 of the $500,000 settlement amount agreed upon by Jolly.15 The Relators Settlement Agreement did not provide for awards to Lawson, Green, Church, or Outerbridge.16

12 R. Doc. No. 55-4, at 9. Recital K of the global settlement agreement also stated that the relators “claim entitlement under 31 U.S.C. § 3730(d) to a share of the proceeds of this Settlement Agreement and to Relators’ reasonable expenses, attorneys’ fees and costs.” Id. at 5. 13 Id. at 9. 14 R. Doc. No. 70-2. 15 Id. at 2. 16 The Relators Settlement Agreement stated that the government “intends to award a share only to Relators Bergeron and McNeil, and Relators do not intend to contest such an award.” Id. II. The False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq., imposes liability on those who defraud the government with false or fraudulent claims for payment or

approval.17 U.S. ex rel. Thompson v. Columbia/HCA Healthcare Corp., 125 F.3d 899, 903 (5th Cir. 1997).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Louisiana Power & Light Co. v. Kellstrom
50 F.3d 319 (Fifth Circuit, 1995)
United States v. United States Ex Rel. Thornton
207 F.3d 769 (Fifth Circuit, 2000)
Walker v. City of Mesquite, TX
313 F.3d 246 (Fifth Circuit, 2002)
Singer v. City of Waco, Texas
324 F.3d 813 (Fifth Circuit, 2003)
Saizan v. Delta Concrete Products Co.
448 F.3d 795 (Fifth Circuit, 2006)
McClain v. Lufkin Industries, Inc.
519 F.3d 264 (Fifth Circuit, 2008)
United States Ex Rel. Longhi v. United States
575 F.3d 458 (Fifth Circuit, 2009)
C & D Production Services v. Director
376 F. App'x 392 (Fifth Circuit, 2010)
Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
City of Burlington v. Dague
505 U.S. 557 (Supreme Court, 1992)
Rockwell International Corp. v. United States
549 U.S. 457 (Supreme Court, 2007)
Gagnon v. United Technisource, Inc.
607 F.3d 1036 (Fifth Circuit, 2010)
Tina Lewallen v. City of Beaumont
394 F. App'x 38 (Fifth Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
McNeil v. Jolly, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcneil-v-jolly-laed-2020.